Q3 Net Loss Widens to $58.1M as R&D Costs Climb; Cash Burn Guidance Trimmed to Low End
EVEX sits 19% above its 52-week low of $1.405.
Summary
Eve's Q3 2026 net loss widened to $58.1 million from $46.9 million a year earlier, driven by higher R&D spending ($48.3 million vs $44.9 million) and weaker net financial results. SG&A fell to $6.0 million from $7.0 million as Embraer cost synergies begin to show. Cash consumption was $55.1 million for the quarter and $173.1 million for the first nine months; management now expects full-year 2026 burn at the low end of its $225-275 million guidance. Cash and investments stood at $356.0 million, with total liquidity of $470.4 million including undrawn BNDES lines and a grant — enough to fund operations through 2028. The company remains pre-revenue, so the widening loss is a development-cost story rather than a demand miss; the key takeaway is that burn is tracking better than the midpoint of guidance while the loss deepens. This follows the October 26 8-K disclosing NYSE delisting of the EVEXW warrants after abnormally low selling prices, a reminder that the capital structure is under pressure. Management discusses results on the 8:00 AM ET call today.
At the time of this announcement, EVEX was trading at $1.67 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $585.5M. The 52-week trading range was $1.41 to $5.16. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: PR Newswire.